fluoxetine and haloperidol

fluoxetine has been researched along with haloperidol in 107 studies

Research

Studies (107)

Timeframe	Studies, this research(%)	All Research%
pre-1990	9 (8.41)	18.7374
1990's	21 (19.63)	18.2507
2000's	39 (36.45)	29.6817
2010's	37 (34.58)	24.3611
2020's	1 (0.93)	2.80

Authors

Authors	Studies
Costanzo, MJ; Gardocki, JF; Maryanoff, BE; McComsey, DF; Nortey, SO; Schneider, CR; Setler, PE; Shank, RP	1
Baldessarini, RJ; Booth, RG; Charifson, PS; Kula, NS; McPhail, AT; Myers, AM; Owens, CE; Wyrick, SD	1
Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM	1
Topliss, JG; Yoshida, F	1
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA	1
Keserü, GM	1
Caron, G; Ermondi, G	1
Nagashima, R; Nishikawa, T; Tobita, M	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Abraham, MH; Acree, WE; Ibrahim, A	1
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H	1
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J	1
Jia, L; Sun, H	1
Bleich, S; Kornhuber, J; Rupprecht, R; Terfloth, L; Wiltfang, J	1
Ahman, M; Holmén, AG; Wan, H	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Ang, KK; Arkin, MR; Chen, S; Doyle, PS; Engel, JC; McKerrow, JH	1
Glen, RC; Lowe, R; Mitchell, JB	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Chen, X; Lin, X; Skolnik, S; Wang, J	1
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F	1
Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ	1
Sen, S; Sinha, N	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T	1
Freiwald, S; Jiang, Y; Jones, JP; Kaspera, R; Katayama, J; Lee, CA; Smith, E; Totah, RA; Walker, GS	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ	1
Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L	1
Peters, JU	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Beaumont, K; Di, L; Maurer, TS; Smith, DA	1
Bennis, K; Ducki, S; Lesage, F; Vivier, D	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Qin, W; Tian, S; Wold, EA; Xu, Q; Ye, N; Zhen, XC; Zhou, J	1
Quock, RM; Weick, BG	1
Górka, Z; Kwiatek, H; Maj, J; Wojtasik, E	1
Baldessarini, RJ; Kula, NS; Marsh, ER	1
Falkenberg, K; Marcoux, GS; Matthews, P; Quinn, D	1
Stein, MH	1
Baldessarini, RJ; Brotman, AW; Goff, DC; Midha, KK; Waites, M	1
Arana, GW; Austin, LS; Melvin, JA	1
Tate, JL	1
Dahms, JL; Seiden, LS; Shaughnessy, RA	1
Jackson, DM; Jenkins, OF	1
Sugrue, MF	1
Delashaw, JB; Dement, WC; Foutz, AS; Guilleminault, C	1
Grandison, L	1
Anderson, GM; Cohen, DJ; Hall, LM	1
Amico, E; Goff, DC; Hubbard, JW; Midha, KK; Sarid-Segal, O	1
Abi-Dargham, A; Bennett, A; D'Souza, DC; Krystal, JH	1
Corbett, R; Cornfeldt, M; Dunn, RW; Smith, C; Szewczak, M; Woods, A	1
Lauterbach, EC	1
De Meester, I; Desnyder, R; Maes, M; Meltzer, HY; Ranjan, R; Scharpe, S	1
Benazzi, F	1
Earley, B; Faherty, CJ; Leonard, BE	1
Cherin, P; Colvez, A; Deville de Periere, G; Sereni, D	1
Auer, SR; Monteiro, IM; Reisberg, B	1
Avenoso, A; Campo, G; Caputi, AP; Facciolă, G; Ferlito, M; Perucca, E; Spinà, E; Zuccaro, P	1
Bhatara, VS; Paul, KL	1
Auchus, AP; Bissey-Black, C	1
Bhattacharya, SK; Jaiswal, AK; Singh, M; Singh, Y	1
Heal, DJ; Kilpatrick, IC; Needham, PL; Rowley, HL	1
Duman, RS; Impey, S; Sakai, N; Shin, K; Steffen, C; Storm, D; Thome, J; Zhang, YJ	1
Marsh, C; Preskorn, SH; Shad, MU	1
Benjamin, D; He, M; Shippenberg, T; Sibille, E; Toth, M	1
Rehavi, M; Roz, N; Weizman, A	1
Garrido Barral, A; González Moneo, MJ	1
Carbone, KM; Moran, TH; Pletnikov, MV; Rubin, SA; Vogel, MW	1
Ginovart, N; Houle, S; Hussey, D; Meyer, JH; Wilson, AA	1
Banti, S; Borri, C; Camilleri, V; Cassano, GB; Mauri, M; Miniati, M; Pini, S; Rotondo, A	1
Conley, RR; Kelly, DL; Kim, YH; Park, JH; Shim, JC; Shin, JG; Yoon, YR	1
Baba, A; Hashimoto, H; Shintani, N; Tanaka, K	1
Cohen, LH; Hollembaek, J; Li, W; Penn, LD; Yu, C	1
Kessler, AR	1
Mackin, P; Young, AH	1
Howell, LL; Kimmel, HL; Lindsey, KP; Wilcox, KM	1
Bonikovski, V; Futuro-Neto, HA; Pires, JG	1
Barsvári, B; Haller, J; Levay, G; Leveleki, C; Mikics, E; Soproni, K; Sziray, N	1
Kolb, Y; Nicolas, LB; Prinssen, EP	1
Blank, M; Brodsky, O; Chapman, J; Katzav, A; Pick, CG; Reichlin, M; Shoenfeld, Y; Solodeev, I; Zhang, W	1
Bintz, B; Emerich, DF; Hudak, J; Schneider, P; Thanos, CG	1
Dai, XM; Lu, Y; Ma, HW; Yao, Y	1
Back, I; Taubert, M	1
Preskorn, SH	1
Harvey, I; Lilford, R; Song, F	1
Lin, Y; Quartermain, D; Stone, EA	1
Hasegawa, R; Ikeda, K; Karasawa, J; Tamura, K; Yamamoto, H; Yamamoto, T; Yasumoto, S	1
Binfaré, RW; Budni, J; Mantovani, M; Rodrigues, AL; Santos, AR	1
Kenchaiah, BK; Kumar, S; Tharyan, P	1
Akagawa, K; Fujiwara, T; Kofuji, T; Snada, M; Yoshikawa, T	1
Gobaille, S; Krezel, W; Krzyzosiak, A; Muramatsu, S; Szyszka-Niagolov, M; Wietrzych, M	1
Oleson, EB; Richardson, JM; Roberts, DC	1
Rushlow, WJ; Sutton, LP	1
Furutani, K; Inanobe, A; Kurachi, Y; Ohno, Y; Yamakawa, Y	1
Bridgman, A; Creed, MC; Fletcher, PJ; Hamani, C; Nobrega, JN	1
Eibak, LE; Gjelstad, A; Oiestad, EL; Pedersen-Bjergaard, S; Rasmussen, KE	1
Avcikurt, AS; Kockar, F; Sinan, S	1
Deng, CM; Gao, YY; Li, Y; Mu, YL; Ou, BC; So, JH; Tan, ZB; Tang, M; Wang, YQ; Zhang, LQ; Zhu, ZR	1
De Montis, MG; Ferrari, A; Gambarana, C; Pelliccia, T; Scheggi, S	1
Collins, SL; Contreras-Mora, HM; Correa, M; Errante, EL; Rowland, MA; Salamone, JD; Yohn, SE	1
Chen, H; Chen, W; Li, M; Qin, J; Sui, N; Yang, Y	1
Eder, M; Hladky, F; Holsboer, F; Schmidt, MV; Stepan, J; Uribe, A	1
Barbacci, DC; Bonci, A; Jackson, SN; Woods, AS	1
Ahmadi, SA; Haddadi, R; Sabahi, M	1

Reviews

7 review(s) available for fluoxetine and haloperidol

Article	Year
The role of receptor binding in drug discovery. Journal of natural products, 1993, Volume: 56, Issue:4 Topics: Animals; Drug Design; Humans; Receptors, Drug	1993
Polypharmacology - foe or friend? Journal of medicinal chemistry, 2013, Nov-27, Volume: 56, Issue:22 Topics: Animals; Communicable Diseases; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Polypharmacology; Safety	2013
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target? Journal of medicinal chemistry, 2016, 06-09, Volume: 59, Issue:11 Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship	2016
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases. Journal of medicinal chemistry, 2020, 12-24, Volume: 63, Issue:24 Topics: Allosteric Regulation; Clinical Trials as Topic; Humans; Ligands; Nervous System Diseases; Piperidines; Receptors, sigma; Sigma-1 Receptor; Small Molecule Libraries	2020
[Latest therapies for treating dementia]. Atencion primaria, 2002, May-15, Volume: 29, Issue:8 Topics: Adult; Aged; Alzheimer Disease; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clinical Trials as Topic; Cognition; Cohort Studies; Controlled Clinical Trials as Topic; Dementia, Vascular; Donepezil; Female; Fluoxetine; Galantamine; Haloperidol; Hormone Replacement Therapy; Humans; Hydroxychloroquine; Indans; Middle Aged; Nootropic Agents; Piperidines; Placebos; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Trazodone	2002
Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions. Journal of clinical epidemiology, 2008, Volume: 61, Issue:5 Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bias; Bupropion; Data Interpretation, Statistical; Drug Therapy; Fluoxetine; Haloperidol; Humans; Imipramine; Meta-Analysis as Topic; Nicotine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Smoking Cessation; Treatment Outcome	2008

Trials

5 trial(s) available for fluoxetine and haloperidol

Article	Year
A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia. Psychopharmacology, 1995, Volume: 117, Issue:4 Topics: Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Fluphenazine; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	1995
Behavioral symptoms in dementia: community-based research. International psychogeriatrics, 1996, Volume: 8 Suppl 3 Topics: Aged; Alzheimer Disease; Ambulatory Care; Antipsychotic Agents; Dementia; Double-Blind Method; Female; Fluoxetine; Follow-Up Studies; Geriatric Assessment; Haloperidol; Humans; Male; Neurocognitive Disorders; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Social Behavior Disorders; Thioridazine	1996
Interaction between fluoxetine and haloperidol: pharmacokinetic and clinical implications. Pharmacological research, 1997, Volume: 35, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Drug Interactions; Female; Fluoxetine; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	1997
Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease. The Journal of neuropsychiatry and clinical neurosciences, 1997,Fall, Volume: 9, Issue:4 Topics: Aged; Alzheimer Disease; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Double-Blind Method; Female; Fluoxetine; Haloperidol; Humans; Male; Pilot Projects; Psychomotor Agitation	1997
Six-month open trial of haloperidol as an adjunctive treatment for anorexia nervosa: a preliminary report. The International journal of eating disorders, 2003, Volume: 33, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Anorexia Nervosa; Body Mass Index; Dopamine Antagonists; Drug Therapy, Combination; Female; Fluoxetine; Haloperidol; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index	2003

Other Studies

95 other study(ies) available for fluoxetine and haloperidol

Article	Year
Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships. Journal of medicinal chemistry, 1987, Volume: 30, Issue:8 Topics: Animals; Antidepressive Agents; Blepharoptosis; Brain; Catecholamines; Chemical Phenomena; Chemistry; Dopamine; Isoquinolines; Male; Molecular Conformation; Motor Activity; Norepinephrine; Pyrroles; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Structure-Activity Relationship; Synaptosomes; Tetrabenazine	1987
Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor. Journal of medicinal chemistry, 1994, Nov-25, Volume: 37, Issue:24 Topics: Animals; Ligands; Models, Molecular; Molecular Conformation; Receptors, sigma; Rodentia; Structure-Activity Relationship; Tetrahydronaphthalenes	1994
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:3 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations	2002
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16 Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship	2003
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk). Journal of medicinal chemistry, 2005, May-05, Volume: 48, Issue:9 Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water	2005
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors. Bioorganic & medicinal chemistry letters, 2005, Jun-02, Volume: 15, Issue:11 Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated	2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs. European journal of medicinal chemistry, 2008, Volume: 43, Issue:3 Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization	2008
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19 Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats	2007
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2 Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase	2008
Support vector machines classification of hERG liabilities based on atom types. Bioorganic & medicinal chemistry, 2008, Jun-01, Volume: 16, Issue:11 Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve	2008
Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors. European journal of medicinal chemistry, 2009, Volume: 44, Issue:6 Topics: Binding Sites; Computer Simulation; Databases, Factual; Models, Chemical; Models, Molecular; Molecular Structure; Molecular Weight; Psychotropic Drugs; Serotonin 5-HT3 Receptor Antagonists; Structure-Activity Relationship	2009
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8 Topics: Animals; Cattle; Cell Line; Cell Line, Tumor; Chagas Disease; Drug Evaluation, Preclinical; Hepatocytes; High-Throughput Screening Assays; Humans; Image Processing, Computer-Assisted; Muscle, Skeletal; Parasitic Sensitivity Tests; Trypanocidal Agents; Trypanosoma cruzi	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2 Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity	2011
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2 Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution	2011
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3 Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results	2011
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model. European journal of medicinal chemistry, 2011, Volume: 46, Issue:2 Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets. Journal of medicinal chemistry, 2012, Jan-12, Volume: 55, Issue:1 Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics	2012
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:5 Topics: Amiodarone; Astemizole; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Danazol; Drug Discovery; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Methylation; Microsomes, Liver; Models, Biological; Molecular Structure; Substrate Specificity; Tandem Mass Spectrometry; Terfenadine	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1 Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity	2013
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells. Bioorganic & medicinal chemistry letters, 2013, Mar-15, Volume: 23, Issue:6 Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship	2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Volume of Distribution in Drug Design. Journal of medicinal chemistry, 2015, Aug-13, Volume: 58, Issue:15 Topics: Drug Design; Half-Life; Pharmacokinetics	2015
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
p-Chloroamphetamine-induced hyperthermia pharmacologically distinct from fenfluramine-induced hyperthermia. The Journal of pharmacy and pharmacology, 1979, Volume: 31, Issue:1 Topics: Amphetamines; Animals; Body Temperature; Brain Stem; Cyproheptadine; Fenclonine; Fenfluramine; Fluoxetine; Haloperidol; Hydrazines; Lysergic Acid Diethylamide; Male; Metergoline; p-Chloroamphetamine; Rabbits; Serotonin; Time Factors	1979
Action of serotoninmimetics in the behavioral despair test in rats. Communications in psychopharmacology, 1979, Volume: 3, Issue:3 Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Fenfluramine; Fluoxetine; Haloperidol; Imipramine; Immobilization; Lysergic Acid Diethylamide; Premedication; Quipazine; Rats; Receptors, Serotonin; Serotonin	1979
Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions. Brain research, 1992, May-01, Volume: 579, Issue:1 Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Fluoxetine; Haloperidol; Male; Rats; Rats, Inbred Strains; Serotonin	1992
Fluoxetine and neuroleptic synergistic effects. Journal of the American Academy of Child and Adolescent Psychiatry, 1991, Volume: 30, Issue:1 Topics: Adolescent; Chlorpromazine; Diseases in Twins; Drug Synergism; Fluoxetine; Haloperidol; Humans; Male; Obsessive-Compulsive Disorder; Substance Withdrawal Syndrome	1991
Tardive dyskinesia in a patient taking haloperidol and fluoxetine. The American journal of psychiatry, 1991, Volume: 148, Issue:5 Topics: Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluoxetine; Haloperidol; Humans; Male; Paranoid Disorders	1991
Elevation of plasma concentrations of haloperidol after the addition of fluoxetine. The American journal of psychiatry, 1991, Volume: 148, Issue:6 Topics: Adult; Aged; Basal Ganglia Diseases; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Haloperidol; Humans; Male; Middle Aged; Psychotic Disorders; Schizophrenia; Stimulation, Chemical	1991
Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients. The Journal of clinical psychiatry, 1990, Volume: 51, Issue:8 Topics: Aged; Antidepressive Agents; Cognition Disorders; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Haloperidol; Humans; Lithium; Nervous System Diseases	1990
Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine. The American journal of psychiatry, 1989, Volume: 146, Issue:3 Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Haloperidol; Humans	1989
Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule. Psychopharmacology, 1985, Volume: 86, Issue:1-2 Topics: Animals; Antidepressive Agents; Bupropion; Clozapine; Drug Evaluation, Preclinical; Electroshock; Fluoxetine; Haloperidol; Male; Propiophenones; Rats; Rats, Inbred Strains; Reinforcement Schedule; Trazodone; Zimeldine	1985
Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice. Naunyn-Schmiedeberg's archives of pharmacology, 1985, Volume: 331, Issue:1 Topics: alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Drug Synergism; Fluoxetine; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Motor Activity; Nomifensine; Receptors, Dopamine; Reserpine	1985
The inability of chronic fluoxetine to potentiate a serotonin mediated effect. Communications in psychopharmacology, 1980, Volume: 4, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Drug Interactions; Fluoxetine; Haloperidol; Homovanillic Acid; Male; Propylamines; Rats; Serotonin	1980
Monoaminergic mechanisms and experimental cataplexy. Annals of neurology, 1981, Volume: 10, Issue:4 Topics: Animals; Antidepressive Agents, Tricyclic; Biogenic Amines; Cataplexy; Dogs; Female; Fluoxetine; Haloperidol; Humans; Male; Methylphenidate; Monoamine Oxidase Inhibitors; Physostigmine; Pimozide; Propranolol; Sleep, REM; Sodium Oxybate	1981
Suppression of prolactin secretion by benzodiazepines in vivo. Neuroendocrinology, 1982, Volume: 34, Issue:5 Topics: 5-Hydroxytryptophan; Animals; Benzodiazepines; Diazepam; Dose-Response Relationship, Drug; Female; Fluoxetine; Haloperidol; Male; Pregnancy; Proestrus; Prolactin; Rats; Rats, Inbred Strains; Restraint, Physical; Stress, Physiological	1982
Acute and chronic effects of fluoxetine and haloperidol on mouse brain serotonin and norepinephrine turnover. Life sciences, 1995, Volume: 57, Issue:8 Topics: Animals; Brain; Dopamine; Fluoxetine; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Mice; Norepinephrine; Rats; Serotonin; Species Specificity	1995
Precipitation of a psychoneuromotor syndrome by fluoxetine in a haloperidol-treated schizophrenic patient. Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:5 Topics: Akathisia, Drug-Induced; Drug Therapy, Combination; Fluoxetine; Haloperidol; Humans; Male; Middle Aged; Myoclonus; Neurologic Examination; Schizophrenia; Schizophrenic Psychology; Tremor	1994
Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder. Psychopharmacology, 1993, Volume: 112, Issue:2-3 Topics: Animals; Clomipramine; Conditioning, Operant; Desipramine; Diazepam; Disease Models, Animal; Drinking Behavior; Fluoxetine; Haloperidol; Male; Obsessive-Compulsive Disorder; Rats; Rats, Wistar; Reinforcement Schedule; Selective Serotonin Reuptake Inhibitors	1993
Reversible intermittent rhythmic myoclonus with fluoxetine in presumed Pick's disease. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:3 Topics: Affective Disorders, Psychotic; Brain; Dementia; Dose-Response Relationship, Drug; Electroencephalography; Fluoxetine; Haloperidol; Humans; Male; Middle Aged; Myoclonus; Serotonin; Trazodone	1994
Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs. Acta psychiatrica Scandinavica, 1996, Volume: 93, Issue:1 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Female; Fluoxetine; Haloperidol; Humans; Hydrocortisone; Imipramine; Male; Middle Aged; Nortriptyline; Perphenazine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	1996
Urinary retention with fluoxetine-haloperidol combination in a young patient. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1996, Volume: 41, Issue:9 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Haloperidol; Humans; Male; Urinary Retention	1996
Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat. Journal of psychopharmacology (Oxford, England), 1997, Volume: 11, Issue:1 Topics: 1-Naphthylamine; Animals; Behavior, Animal; Chlorpromazine; Citalopram; Fluoxetine; Fluvoxamine; Guanidines; Haloperidol; Male; Microinjections; Motor Activity; Paroxetine; Piperidines; Posture; Rats; Rats, Sprague-Dawley; Receptors, sigma; Red Nucleus; Selective Serotonin Reuptake Inhibitors; Sertraline	1997
Risk of syncope in the elderly and consumption of drugs: a case-control study. Journal of clinical epidemiology, 1997, Volume: 50, Issue:3 Topics: Acepromazine; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Antipsychotic Agents; Case-Control Studies; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; Fluoxetine; Haloperidol; Humans; Levodopa; Male; Matched-Pair Analysis; Pharmacoepidemiology; Risk; Syncope	1997
Anticholinergic delirium possibly associated with protriptyline and fluoxetine. The Annals of pharmacotherapy, 1997, Volume: 31, Issue:10 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cholinergic Antagonists; Cytochrome P-450 CYP2D6 Inhibitors; Delirium; Female; Fluoxetine; Hallucinations; Haloperidol; Humans; Middle Aged; Protriptyline	1997
Effect of prenatal diazepam, phenobarbital, haloperidol and fluoxetine exposure on foot shock induced aggression in rats. Indian journal of experimental biology, 1998, Volume: 36, Issue:10 Topics: Aggression; Animals; Diazepam; Drug Evaluation, Preclinical; Electroshock; Female; Fluoxetine; Haloperidol; Phenobarbital; Pregnancy; Prenatal Exposure Delayed Effects; Psychotropic Drugs; Rats	1998
A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo. Naunyn-Schmiedeberg's archives of pharmacology, 2000, Volume: 361, Issue:2 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dibenzothiepins; Dopamine; Fluoxetine; Frontal Lobe; Haloperidol; Male; Microdialysis; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Serotonin	2000
cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000, Jun-01, Volume: 20, Issue:11 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; beta-Galactosidase; Brain Chemistry; Cocaine; Coloring Agents; Cyclic AMP Response Element-Binding Protein; Desipramine; Dopamine Uptake Inhibitors; Fluoxetine; Haloperidol; Lac Operon; Mice; Mice, Transgenic; Monoamine Oxidase Inhibitors; Phosphorylation; Transcription, Genetic; Tranylcypromine; Up-Regulation	2000
The economic consequences of a drug-drug interaction. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:1 Topics: Aged; Antipsychotic Agents; Benzodiazepines; Depression; Drug Interactions; Female; Fluoxetine; Haloperidol; Health Care Costs; Humans; Olanzapine; Parkinson Disease; Pirenzepine; Selegiline; Trihexyphenidyl	2001
Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis. Brain research, 2001, May-25, Volume: 902, Issue:1 Topics: Animals; Brain; Carrier Proteins; Corpus Striatum; Dopamine; Fluoxetine; Haloperidol; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Knockout; Microdialysis; Nerve Tissue Proteins; Receptors, Presynaptic; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Spiperone	2001
Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2002, Volume: 12, Issue:3 Topics: Animals; Antipsychotic Agents; Binding Sites; Biological Transport; Brain; Brain Chemistry; Clozapine; Drug Administration Schedule; Fluoxetine; Haloperidol; In Situ Hybridization; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Paroxetine; Piperazines; Rats; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2002
Effects of genetic background on neonatal Borna disease virus infection-induced neurodevelopmental damage. II. Neurochemical alterations and responses to pharmacological treatments. Brain research, 2002, Jul-19, Volume: 944, Issue:1-2 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animal Diseases; Animals; Animals, Newborn; Borna Disease; Brain; Brain Chemistry; Carrier Proteins; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Fenclonine; Fluoxetine; Genetic Predisposition to Disease; Haloperidol; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurons; Neurotransmitter Agents; Norepinephrine; Pregnancy; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Neurotransmitter; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Plasma Membrane Transport Proteins	2002
[11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats. Synapse (New York, N.Y.), 2003, Volume: 47, Issue:2 Topics: Adrenergic Uptake Inhibitors; Animals; Benzylamines; Brain; Carrier Proteins; Cats; Citalopram; Dopamine Antagonists; Fluoxetine; Haloperidol; Maprotiline; Membrane Glycoproteins; Membrane Transport Proteins; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time Factors; Tissue Distribution; Tomography, Emission-Computed; Tranylcypromine	2003
Fluoxetine augmentation of haloperidol in chronic schizophrenia. Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:5 Topics: Adult; Chi-Square Distribution; Chronic Disease; Drug Synergism; Female; Fluoxetine; Haloperidol; Humans; Male; Middle Aged; Schizophrenia	2003
[Altered behavioral response to centrally acting drugs in mice lacking PACAP]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2003, Volume: 122 Suppl Topics: Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Disease Models, Animal; Fluoxetine; Haloperidol; Mice; Mice, Knockout; Neuropeptides; Pituitary Adenylate Cyclase-Activating Polypeptide; Risperidone	2003
Enzymatic tissue digestion as an alternative sample preparation approach for quantitative analysis using liquid chromatography-tandem mass spectrometry. Analytical chemistry, 2004, Mar-15, Volume: 76, Issue:6 Topics: Animals; Antidepressive Agents; Brain; Chromatography, Liquid; Collagenases; Desipramine; Dogs; Dose-Response Relationship, Drug; Endopeptidase K; Esterases; Feasibility Studies; Female; Fluoxetine; Haloperidol; In Vitro Techniques; Mass Spectrometry; Rats; Rats, Sprague-Dawley; Time Factors	2004
Effects of medications on regulation of body temperature of patients with Tourette syndrome. Journal of child neurology, 2004, Volume: 19, Issue:3 Topics: Adolescent; Adult; Body Temperature Regulation; Child; Child, Preschool; Circadian Rhythm; Clonidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Haloperidol; Humans; Hypothalamic Diseases; Male; Middle Aged; Neurologic Examination; Pimozide; Tourette Syndrome; Treatment Outcome	2004
Reply to Dr. J-C Shim and colleagues regarding "Fluoxetine augmentation of haloperidol in chronic schizophrenia" [J Clin Psychopharmacol 2003;23:520-521]. Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:6 Topics: Drug Synergism; Drug Therapy, Combination; Fluoxetine; Haloperidol; Humans; Schizophrenia	2004
Olanzapine-induced suppression of cocaine self-administration in rhesus monkeys. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:3 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Cocaine-Related Disorders; Data Interpretation, Statistical; Dopamine; Dose-Response Relationship, Drug; Female; Fluoxetine; Haloperidol; Macaca mulatta; Male; Microdialysis; Olanzapine; Selective Serotonin Reuptake Inhibitors; Self Administration	2006
Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2005, Volume: 38, Issue:12 Topics: Animals; Anti-Dyskinesia Agents; Catalepsy; Disease Models, Animal; Female; Fluoxetine; Haloperidol; Male; Mice; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Time Factors	2005
Pharmacological evaluation of the stress-induced social avoidance model of anxiety. Brain research bulletin, 2006, Mar-31, Volume: 69, Issue:2 Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Buspirone; Chlordiazepoxide; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Haloperidol; Male; Models, Neurological; Motor Activity; Phobic Disorders; Piperazines; Rats; Rats, Wistar; Reproducibility of Results; Serotonin Receptor Agonists; Stress, Psychological	2006
A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants. European journal of pharmacology, 2006, Oct-10, Volume: 547, Issue:1-3 Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Behavior, Animal; Diazepam; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoxetine; Haloperidol; Imidazoles; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred CBA; Morphine; Motor Activity; Obsessive-Compulsive Disorder; Pyridines; Reproducibility of Results; Species Specificity; Spiro Compounds	2006
Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis and rheumatism, 2007, Volume: 56, Issue:3 Topics: Animals; Antibodies, Anti-Idiotypic; Antidepressive Agents, Second-Generation; Autoimmunity; Brain; Cognition; Depression; Disease Models, Animal; Female; Fluoxetine; Haloperidol; Limbic System; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C3H; Motor Activity; Physical Exertion; Ribosomal Proteins; Rotarod Performance Test	2007
In vitro exposure of cultured porcine choroid plexus epithelial cells to immunosuppressant, anti-inflammatory, and psychoactive drugs. Cell transplantation, 2007, Volume: 16, Issue:4 Topics: Animals; Cell Survival; Cells, Cultured; Choroid Plexus; Cyclosporine; Epithelial Cells; Fluoxetine; Haloperidol; Immunosuppressive Agents; Naphthalenes; Psychotropic Drugs; Sus scrofa; Vascular Endothelial Growth Factor A	2007
[Roles of fluoxetine and haloperidol in mouse models of DOI-induced head twitch response]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2007, Volume: 9, Issue:5 Topics: Amphetamines; Animals; Disease Models, Animal; Dopamine; Fluoxetine; Haloperidol; Homovanillic Acid; Male; Mice; Receptor, Serotonin, 5-HT1A; Tourette Syndrome	2007
Akathisia and an unusual symptomatic treatment: a case report. Palliative medicine, 2007, Volume: 21, Issue:8 Topics: Akathisia, Drug-Induced; Cyclizine; Exercise Therapy; Female; Fluoxetine; Haloperidol; Humans; Methotrimeprazine; Middle Aged; Ovarian Neoplasms; Oxycodone; Palliative Care; Treatment Outcome	2007
Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic. Journal of psychiatric practice, 2008, Volume: 14, Issue:1 Topics: Aged; Anti-Infective Agents; Antiparkinson Agents; Antipsychotic Agents; Bacteriuria; Ciprofloxacin; Dementia; Drug Interactions; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Fluoxetine; Haloperidol; Hospitalization; Humans; Hypnotics and Sedatives; Lorazepam; Parkinson Disease; Psychomotor Agitation; Selegiline; Trihexyphenidyl	2008
Evaluation of the repeated open-space swim model of depression in the mouse. Pharmacology, biochemistry, and behavior, 2008, Volume: 91, Issue:1 Topics: Adaptation, Psychological; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cell Proliferation; Chronic Disease; Depression; Desipramine; Diazepam; Disease Models, Animal; Fluoxetine; Food Preferences; Haloperidol; Hindlimb Suspension; Hypnotics and Sedatives; Male; Mice; Motor Activity; Neurons; Swimming	2008
Inhibitory effect of selective serotonin reuptake inhibitors on the vesicular monoamine transporter 2. Neuroscience letters, 2009, May-01, Volume: 454, Issue:3 Topics: Animals; Dopamine; Fluoxetine; Fluvoxamine; Haloperidol; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Rats; Rats, Wistar; Reserpine; Selective Serotonin Reuptake Inhibitors; Synaptic Vesicles; Vesicular Monoamine Transport Proteins	2009
Involvement of dopamine receptors in the antidepressant-like effect of melatonin in the tail suspension test. European journal of pharmacology, 2010, Jul-25, Volume: 638, Issue:1-3 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Apomorphine; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Drug Synergism; Fluoxetine; Haloperidol; Immobility Response, Tonic; Male; Melatonin; Mice; Motor Activity; Sulpiride	2010
Atypical anti-psychotics in delusional parasitosis: a retrospective case series of 20 patients. International journal of dermatology, 2010, Volume: 49, Issue:1 Topics: Antipsychotic Agents; Benzodiazepines; Ectoparasitic Infestations; Female; Fluoxetine; Haloperidol; Humans; Imipramine; Male; Middle Aged; Olanzapine; Pimozide; Retrospective Studies; Risperidone; Schizophrenia, Paranoid; Sertraline	2010
HPC-1/syntaxin 1A gene knockout mice show abnormal behavior possibly related to a disruption in 5-HTergic systems. The European journal of neuroscience, 2010, Volume: 32, Issue:1 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Uptake Inhibitors; Amphetamines; Animals; Behavior, Animal; Desipramine; Dopamine Agonists; Dopamine Antagonists; Fluoxetine; Haloperidol; Hippocampus; Humans; Hypothalamus; Inhibition, Psychological; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Piperazines; Quinpirole; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Social Behavior; Syntaxin 1	2010
Retinoid x receptor gamma control of affective behaviors involves dopaminergic signaling in mice. Neuron, 2010, Jun-24, Volume: 66, Issue:6 Topics: Animals; Antidepressive Agents; Behavior, Animal; Cell Count; Dependovirus; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Fluoxetine; Food Preferences; Gene Expression Regulation; Haloperidol; Immobility Response, Tonic; Mice; Mice, Knockout; Mood Disorders; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Receptors, Dopamine D2; Receptors, Retinoic Acid; Retinoid X Receptor gamma; RNA, Messenger; Serotonin; Signal Transduction	2010
A novel IV cocaine self-administration procedure in rats: differential effects of dopamine, serotonin, and GABA drug pre-treatments on cocaine consumption and maximal price paid. Psychopharmacology, 2011, Volume: 214, Issue:2 Topics: Analysis of Variance; Animals; Appetitive Behavior; Baclofen; Behavior, Animal; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Consummatory Behavior; Dopamine Antagonists; Dose-Response Relationship, Drug; Fluoxetine; GABA-B Receptor Agonists; Haloperidol; Infusions, Intravenous; Male; Models, Theoretical; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Selective Serotonin Reuptake Inhibitors; Self Administration; Time Factors	2011
The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling. Neuroscience, 2011, Dec-29, Volume: 199 Topics: Animals; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; beta Catenin; Blotting, Western; Brain; Clozapine; Fluoxetine; Glycogen Synthase Kinase 3; Haloperidol; Imipramine; Immunoprecipitation; Lithium; Male; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Valproic Acid	2011
Pharmacophore modeling for hERG channel facilitation. Biochemical and biophysical research communications, 2012, Feb-03, Volume: 418, Issue:1 Topics: Animals; Atenolol; Chlorpheniramine; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluoxetine; Haloperidol; Humans; Hydrophobic and Hydrophilic Interactions; Imipramine; Metoprolol; Nortriptyline; Potassium Channel Blockers; Promethazine; Propranolol; Quantitative Structure-Activity Relationship; Sotalol; Terfenadine; Verapamil; Xenopus laevis	2012
Contribution of decreased serotonin release to the antidyskinetic effects of deep brain stimulation in a rodent model of tardive dyskinesia: comparison of the subthalamic and entopeduncular nuclei. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Jul-11, Volume: 32, Issue:28 Topics: 5,7-Dihydroxytryptamine; Amphetamines; Analysis of Variance; Animals; Antipsychotic Agents; Autoradiography; Benzylamines; Carbon Isotopes; Chromatography, High Pressure Liquid; Deep Brain Stimulation; Disease Models, Animal; Electrochemical Techniques; Entopeduncular Nucleus; Exploratory Behavior; Fluoxetine; Haloperidol; Hydroxyindoleacetic Acid; Male; Mastication; Microdialysis; Movement Disorders; Protein Binding; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Subthalamic Nucleus	2012
Parallel electromembrane extraction in the 96-well format. Analytica chimica acta, 2014, May-30, Volume: 828 Topics: Amitriptyline; Chromatography, High Pressure Liquid; Electrochemical Techniques; Fluoxetine; Haloperidol; High-Throughput Screening Assays; Humans; Mass Spectrometry; Molecular Structure	2014
Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity. Journal of enzyme inhibition and medicinal chemistry, 2015, Volume: 30, Issue:2 Topics: Acepromazine; Antidepressive Agents; Antipsychotic Agents; Aryldialkylphosphatase; Diazepam; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Female; Fluoxetine; Haloperidol; Humans; Kinetics; Molecular Structure	2015
Dopamine D2/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test. Behavioural brain research, 2015, Feb-15, Volume: 279 Topics: Animals; Antidepressive Agents; Benzazepines; Benzothiazoles; Dizocilpine Maleate; Fluoxetine; Haloperidol; Ketamine; Male; Mice; Motor Activity; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, N-Methyl-D-Aspartate; Swimming	2015
Impramine, fluoxetine and clozapine differently affected reactivity to positive and negative stimuli in a model of motivational anhedonia in rats. Neuroscience, 2015, Apr-16, Volume: 291 Topics: Anhedonia; Animals; Antidepressive Agents; Antipsychotic Agents; Clozapine; Dietary Sucrose; Disease Models, Animal; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Eating; Fluoxetine; Haloperidol; Imipramine; Lithium Compounds; Male; Motivation; Nucleus Accumbens; Phosphorylation; Rats, Sprague-Dawley; Stress, Psychological	2015
Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016, Volume: 41, Issue:3 Topics: Animals; Antidepressive Agents; Benzazepines; Bupropion; Choice Behavior; Desipramine; Dopamine Antagonists; Dose-Response Relationship, Drug; Fluoxetine; Haloperidol; Male; Motivation; Neurotransmitter Uptake Inhibitors; Piperazines; Rats, Sprague-Dawley; Tetrabenazine; Vesicular Monoamine Transport Proteins	2016
Behavioral and pharmacological investigation of anxiety and maternal responsiveness of postpartum female rats in a pup elevated plus maze. Behavioural brain research, 2015, Oct-01, Volume: 292 Topics: Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Dopamine D2 Receptor Antagonists; Female; Fluoxetine; Haloperidol; Maternal Behavior; Maze Learning; Motivation; Postpartum Period; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors	2015
High-Speed imaging reveals opposing effects of chronic stress and antidepressants on neuronal activity propagation through the hippocampal trisynaptic circuit. Frontiers in neural circuits, 2015, Volume: 9 Topics: Animals; Antidepressive Agents; Azepines; Benzamides; Brain-Derived Neurotrophic Factor; Central Nervous System Agents; Chronic Disease; Diazepam; Disease Models, Animal; Dominance-Subordination; Fluoxetine; Haloperidol; Hippocampus; Ketamine; Lithium Compounds; Male; Mice, Inbred C57BL; Neural Pathways; Stress, Psychological; Tissue Culture Techniques; Voltage-Sensitive Dye Imaging	2015
An In Vitro Study of Aromatic Stacking of Drug Molecules. Journal of the American Society for Mass Spectrometry, 2019, Volume: 30, Issue:7 Topics: Anti-Anxiety Agents; Antidepressive Agents; Antineoplastic Agents, Phytogenic; Binding Sites; Diazepam; Drug Interactions; Fluoxetine; Haloperidol; Humans; Models, Molecular; Paclitaxel; Sertraline; Spectrometry, Mass, Electrospray Ionization	2019
The effect of acute and repeated administration of buspirone, 8-OHDPAT and fluoxetine on haloperidol-induced extrapyramidal symptoms. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2019, Volume: 21, Issue:2 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Catalepsy; Fluoxetine; Haloperidol; Male; Pyramidal Cells; Rats; Rats, Wistar	2019